Stock MPH MEREO BIOPHARMA GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Mereo BioPharma Group plc London S.E.

Equities

MPH

GB00BZ4G2K23

Delayed London S.E.
Other stock markets
 		5-day change 1st Jan Change
- GBX -.--% Intraday chart for Mereo BioPharma Group plc -10.17% -.--%
Apr. 26 European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4% MT
Apr. 24 European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Needham Adjusts Price Target on Mereo BioPharma to $6 From $5, Keeps Buy Rating
MT
Ultragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI)
CI
Shift to Fed's Rate Hike Path, Better Outlook on UBS-Credit Suisse Deal Pushes US Equities Up
MT
European Equities Move Lower Following ECB Rate Hike
MT
SVB Securities Trims Price Target on Mereo BioPharma Group to $4 From $8, Maintains Outperform Rating
MT
Cantor Fitzgerald Starts Mereo BioPharma Group at Overweight With $4 Price Target
MT
Needham Adjusts Price Target on Mereo BioPharma Group to $5 From $10, Reiterates Buy Rating
MT
MEREO BIOPHARMA : BTIG Initiates Mereo BioPharma at Buy Rating With $10 Price Target
MT
MEREO BIOPHARMA : Needham Starts Mereo BioPharma Group at Buy With $10 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MREO Stock
  4. MPH Stock
  5. News Mereo BioPharma Group plc
  6. Analyst Reco.